Literature DB >> 4591489

Altered serum clearance of intravenously administered clindamycin phosphate in patients with uremia.

A M Joshi, R M Stein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4591489     DOI： 10.1002/j.1552-4604.1974.tb02304.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  4 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Effect of peritoneal dialysis on serum levels of tobramycin and clindamycin.

Authors:  R F Malacoff; F O Finkelstein; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

3.  Protein binding of clindamycin in sera of patients with AIDS.

Authors:  J F Flaherty; G Gatti; J White; J Bubp; M Borin; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

4.  Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1977-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.